What’s next for the Biden administration’s Medicare drug price negotiations

[ad_1] U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event…

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

[ad_1] An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg |…

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

[ad_1] Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool…

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

[ad_1] Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked…

Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching

[ad_1] Investors want to know whether Eli Lilly is seeing the same pricing pressures on its…

Want to invest $50,000? Here are 5 ETFs to buy and hold, according to a wealth manager

[ad_1] 2024 was expected to be a ” stock picker’s year ,” but macroeconomic uncertainties and…

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

[ad_1] An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New…

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

[ad_1] Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der…

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

[ad_1] A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter…

These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments

[ad_1] The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at…

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says

[ad_1] Weight loss drugs have drawn investor interest and shaken up other sectors in the past…

Viking Therapeutics stock jumps nearly 30% after drugmaker moves weight loss injection to late-stage trial

[ad_1] Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped…

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…